These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 27278789)

  • 1. The roles of microRNAs in the progression of castration-resistant prostate cancer.
    Kojima S; Goto Y; Naya Y
    J Hum Genet; 2017 Jan; 62(1):25-31. PubMed ID: 27278789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of LSD1 by Pargyline inhibited process of EMT and delayed progression of prostate cancer in vivo.
    Wang M; Liu X; Guo J; Weng X; Jiang G; Wang Z; He L
    Biochem Biophys Res Commun; 2015 Nov; 467(2):310-5. PubMed ID: 26435505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of TXNDC5 in castration-resistant prostate cancer-involvement of androgen receptor signaling pathway.
    Wang L; Song G; Chang X; Tan W; Pan J; Zhu X; Liu Z; Qi M; Yu J; Han B
    Oncogene; 2015 Sep; 34(36):4735-45. PubMed ID: 25500540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer.
    Gu P; Chen X; Xie R; Xie W; Huang L; Dong W; Han J; Liu X; Shen J; Huang J; Lin T
    Mol Cancer; 2019 Jun; 18(1):109. PubMed ID: 31221168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microdissecting the role of microRNAs in the pathogenesis of prostate cancer.
    Ayub SG; Kaul D; Ayub T
    Cancer Genet; 2015 Jun; 208(6):289-302. PubMed ID: 26004033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leading causes of castration-resistant prostate cancer.
    Lu M; Lu H; Kong Q
    Expert Rev Anticancer Ther; 2015 Apr; 15(4):425-32. PubMed ID: 25645203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
    Gui B; Hsieh CL; Kantoff PW; Kibel AS; Jia L
    PLoS One; 2017; 12(9):e0184166. PubMed ID: 28886115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive proteomic profiling identifies the androgen receptor axis and other signaling pathways as targets of microRNAs suppressed in metastatic prostate cancer.
    Coarfa C; Fiskus W; Eedunuri VK; Rajapakshe K; Foley C; Chew SA; Shah SS; Geng C; Shou J; Mohamed JS; O'Malley BW; Mitsiades N
    Oncogene; 2016 May; 35(18):2345-56. PubMed ID: 26364608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptors in hormone-dependent and castration-resistant prostate cancer.
    Shafi AA; Yen AE; Weigel NL
    Pharmacol Ther; 2013 Dec; 140(3):223-38. PubMed ID: 23859952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Androgen receptor variants in prostate cancer].
    Schreyer E; Barthélémy P; Cottard F; Ould Madi-Berthélémy P; Schaff-Wendling F; Kurtz JE; Céraline J
    Med Sci (Paris); 2017; 33(8-9):758-764. PubMed ID: 28945566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism.
    Shih JW; Wang LY; Hung CL; Kung HJ; Hsieh CL
    Int J Mol Sci; 2015 Dec; 16(12):28943-78. PubMed ID: 26690121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor co-regulatory networks in castration-resistant prostate cancer.
    Sung YY; Cheung E
    Endocr Relat Cancer; 2014 Feb; 21(1):R1-R11. PubMed ID: 24152433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA expression signature of castration-resistant prostate cancer: the microRNA-221/222 cluster functions as a tumour suppressor and disease progression marker.
    Goto Y; Kojima S; Nishikawa R; Kurozumi A; Kato M; Enokida H; Matsushita R; Yamazaki K; Ishida Y; Nakagawa M; Naya Y; Ichikawa T; Seki N
    Br J Cancer; 2015 Sep; 113(7):1055-65. PubMed ID: 26325107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives.
    Hu J; Wang G; Sun T
    Tumour Biol; 2017 May; 39(5):1010428317692259. PubMed ID: 28475016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tpl2 induces castration resistant prostate cancer progression and metastasis.
    Lee HW; Cho HJ; Lee SJ; Song HJ; Cho HJ; Park MC; Seol HJ; Lee JI; Kim S; Lee HM; Choi HY; Nam DH; Joo KM
    Int J Cancer; 2015 May; 136(9):2065-77. PubMed ID: 25274482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classical and Non-Classical Roles for Pre-Receptor Control of DHT Metabolism in Prostate Cancer Progression.
    Zhang A; Zhang J; Plymate S; Mostaghel EA
    Horm Cancer; 2016 Apr; 7(2):104-13. PubMed ID: 26797685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of PCA 3 as a Prognostic Factor in Patients with Castration-resistant Prostate Cancer (CRPC) Treated with Docetaxel.
    Bourdoumis A; Chrisofos M; Stasinou T; Christopoulos P; Mourmouris P; Kostakopoulos A; Deliveliotis C
    Anticancer Res; 2015 May; 35(5):3075-9. PubMed ID: 25964598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA‑149 inhibits cancer cell malignant phenotype by regulating Akt1 in C4‑2 CRPC cell line.
    Zhao J; Li Q; Feng B; Wei D; Han Y; Li M; Wang Y; Luo Y; Jiang Y
    Oncol Rep; 2021 Dec; 46(6):. PubMed ID: 34698359
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Fararjeh AS; Liu YN
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31181727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of tumor cell plasticity by the androgen receptor in prostate cancer.
    Bishop JL; Davies A; Ketola K; Zoubeidi A
    Endocr Relat Cancer; 2015 Jun; 22(3):R165-82. PubMed ID: 25934687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.